Morimiru’s scientific advisor, AIST’s Junsuke Tomita, developed a rapid method for assessing culture media and supplements using fluorescence polymers and machine learning, published in *Chemical Science*.
The company’s representative, 森, received the Japanese Neurological Society Award (Academic Research Division) at the 67th Japanese Neurological Society Meeting held May 20–23, 2026.
The Japanese Neurological Society produced a special video featuring杉江 和馬, a scientific advisor to the company and professor of neurology at Nara Medical University. The video highlights advancements in neurology and the role of neurologists in addressing diseases like dementia and Parkinson’s in an aging society.
Morimiru founder trained at Nara Medical University Hospital, University of Texas Southwestern Medical Center, and Nara Medical University before founding the company.
Morimiru uses proprietary molecular motion analysis (CHEmir) and NMR techniques (MAGmir), alongside clinical experts and scientific advisors, to address challenges across drug discovery.
molmir Inc. developed a technology to observe molecular dynamics—how molecules move and interact—based on research into phase separation in living cells. This approach enables previously untargetable, shape-shifting molecules to become candidates for new drugs.
